Of note, research by Lang and colleagues revealed that HDAC4 was an upstream regulator of PD progression, and HDAC4-modulating compounds, such as tasquinimod, had great therapeutic potential for neuroprotection in PD [29]. The gene discussed is HDAC4; the disease is Parkinson disease.